Low molecular weight heparin reduces proteinuria and modulates glomerular TNF-α production in the early phase of adriamycin nephropathy

被引:13
作者
Benchetrit, S
Golan, E
Podjarny, E
Green, J
Rashid, G
Bernheim, J [1 ]
Hershkovitz, R
Bernheim, J [1 ]
机构
[1] Meir Gen Hosp, Dept Hypertens & Nephrol, Kfar Saba, Israel
[2] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel
来源
NEPHRON | 2001年 / 87卷 / 02期
关键词
adriamycin; low molecular weight heparin; glomerular tumor necrosis factor alpha proteinuria;
D O I
10.1159/000045905
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background/Aim: Heparin has been shown to be renoprotective in a number of experimental nephropathies. The inflammatory component in the early phase of Adriamycin (ADR) induced nephropathy has been established. A microdose of low molecular weight heparin (Fragmin; F) has been noted to exert immunomodulatory effects independent of its anticoagulant activity. We assessed the effects of microdoses of F on daily proteinuria and glomerular production of tumor necrosis factor alpha (TNF-alpha) and prostaglandins 8 and 15 days after induction of ADR nephropathy. Methods: Following intravenous injection of ADR (7 mg/kg) to Wistar rats weighing 200 +/- 20 g, F 20 mug/day/rat s.c. was administered for 8 and 15 days (groups F8 and F15). The respective control groups (C8 and C15) received normal saline subcutaneously. Proteinuria, serum albumin, and creatinine clearance were evaluated on days 8 and 15. The production of TNF-alpha and prostaglandins from glomerular supernatants was measured by radioimmunoassay on days 8 and 15. Results: F significantly reduced proteinuria (mg/day) on day 8: 13.6 +/- 1.2 in F8 versus 40.3 +/- 2.7 in C8 (p = 0.008). The glomerular production of TNF-alpha (pi/ml) was significantly lower on day 8 in rats treated with F: 356 +/- 33 in F8 versus 764 +/- 81 in C8 (p = 0.006). A decrease in the prostaglandin E-2/thromboxane Ba ratio was noted in the F group between 8 and 15 days (1.1 in F8 vs. 0.9 in F15, p = 0.005) which principally reflects an increase of thromboxane B-2 The antiproteinuric effect of F shown after 8 days was no longer present after 15 days (354 +/- 91 mg/day in F15 vs. 499 +/- 69 mg/day in C15, p = 0.33). The same trend was seen for the glomerular production of TNF-alpha. Light microscopy and immunohistochemistry for interstitial and glomerular macrophages were negative. Conclusion: The lowering effect of microdoses of F on the proteinuria seen during the early phase of ADR nephropathy may be mediated by a decreased production of glomerular TNF-alpha, supporting the anti-inflammatory action of low molecular weight heparin. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:155 / 160
页数:6
相关论文
共 30 条
[1]  
Amore A, 1996, NEPHROL DIAL TRANSPL, V11, P1012
[2]   Inhibitory effects of low molecular weight heparin on mediator release by mast cells: preferential inhibition of cytokine production and mast cell dependent cutaneous inflammation [J].
Baram, D ;
Rashkovsky, M ;
Hershkoviz, R ;
Drucker, I ;
Reshef, T ;
Ben-Shitrit, S ;
Mekori, YA .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 110 (03) :485-491
[3]  
BERTANI T, 1982, LAB INVEST, V46, P16
[4]  
BRICIO T, 1992, CLIN EXP IMMUNOL, V87, P117
[5]  
CASTELLOT JJ, 1985, AM J PATHOL, V120, P427
[6]  
CHEN ZY, 1992, CHINESE MED J-PEKING, V105, P671
[7]  
COFFEY AK, 1985, AM J PATHOL, V120, P248
[8]  
DIAMOND JR, 1986, RENAL PHYSIOL BIOCH, V9, P366
[9]   HEPARIN SUPPRESSES MESANGIAL CELL-PROLIFERATION AND MATRIX EXPANSION IN EXPERIMENTAL MESANGIOPROLIFERATIVE GLOMERULONEPHRITIS [J].
FLOEGE, J ;
ENG, E ;
YOUNG, BA ;
COUSER, WG ;
JOHNSON, RJ .
KIDNEY INTERNATIONAL, 1993, 43 (02) :369-380
[10]   Glycosaminoglycans: A new paradigm in the prevention of proteinuria and progression of glomerular disease [J].
Gambaro, G ;
Baggio, B .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 (05) :762-764